Clinical Trial Update: Evaluation of the Efficacy for Sentinel Lymph Node Policy in Intermediate-risk Endometrial Carcinomas [NA]

View source ↗

Summary

A clinical trial evaluating sentinel lymph node policy in intermediate-risk endometrial cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Fudan University | Conditions: Endometrial Endometrioid Adenocarcinoma | NA | Status: WITHDRAWN